Annual Statements Open main menu

PetVivo Holdings, Inc. - Quarter Report: 2012 June (Form 10-Q)

tenp_10q.htm


UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
x
QUARTERLY REPORT UNDER SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the quarterly period ended June 30, 2012
 
o
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
 
For the transition period from to                                 
 
Commission file number: 333-173569
 
Technologies Scan Corp.
(Exact name of registrant as specified in its charter)
 
Nevada
 
99-0363559
(State or other jurisdiction
of incorporation or organization)
 
(IRS Employer
Identification No.)
   
331 Labelle, St-Jerome,
Quebec, Canada, J7Z 5L2
(Address of principal executive offices) (Zip Code)
 
(855) 492-5245
(Registrant’s telephone number, including area code)
 
Indicate by check mark whether the issuer (1) has filed all reports required to be filed by Section 13 or 15(d) of the Exchange Act during the past 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.  x Yes   o No
 
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). o  Yes   x No
 
Indicate by check mark whether the registrant is a large accelerated file, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
 
Large accelerated filer
o
 
 Accelerated filer
o
Non-accelerated filer
o
 (Do not check if a smaller reporting company)
 Smaller reporting company
x
 
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). x Yes  o No
 
As of August 13, 2012, there were 114,150,000 shares of the issuer’s $.001 par value common stock issued and outstanding.
 


 
 

 
 
TABLE OF CONTENTS
 
PART I
FINANCIAL INFORMATION
   
Page
Item 1.
Financial Statements
3
Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
13
Item 3.
Quantitative and Qualitative Disclosures About Market Risk
15
Item 4.
Controls and Procedures
15
     
PART II
OTHER INFORMATION
     
Item 1.
Legal Proceedings
16
Item 1A.
Risk Factors
16
Item 2.
Unregistered Sales of Equity Securities and Use of Proceeds
16
Item 3.
Defaults Upon Senior Securities
16
Item 4.
Mine Safety Disclosures
16
Item 5.
Other Information
16
Item 6.
Exhibits
16
 
 
2

 
 
PART I - FINANCIAL INFORMATION
Item 1. Financial Statements.
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
CONDENSED BALANCE SHEETS
JUNE 30, 2012 AND MARCH 31, 2012
(UNAUDITED)
 
ASSETS
           
   
JUNE 30,
   
MARCH 31,
 
   
2012
   
2012
 
   
(UNAUDITED)
       
CURRENT ASSETS
           
Cash
  $ 385     $ 225  
Other receivable
    1,216       554  
Other current asset
    -       573  
Total current assets
    1,601       1,352  
                 
TOTAL ASSETS
  $ 1,601     $ 1,352  
                 
                 
LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
               
                 
CURRENT LIABILITIES
               
Accounts payable and accrued expenses
  $ 61,948     $ 60,929  
Advances payable
    15,000       15,000  
Advances payable - shareholders
    125,694       103,042  
Total current liabilities     202,642       178,971  
                 
TOTAL LIABILITIES
    202,642       178,971  
                 
STOCKHOLDERS' EQUITY (DEFICIT)
               
   Common stock, $0.001 par value, 200,000,000 shares authorized,
               
    114,150,000 shares issued and outstanding as of March 31, 2012
               
and March 31, 2011, respectively.
    114,150       114,150  
   Additional paid in capital
    74,300       74,300  
   Deficit accumulated during the development stage
    (389,804 )     (366,070 )
Accumulated other comprehensive income
    313       1  
      (201,041 )     (177,619 )
                 
TOTAL LIABILITIES AND STOCKHOLDERS' EQUITY (DEFICIT)
  $ 1,601     $ 1,352  
 
 The accompanying notes are an integral part of these financial statements.
 
 
3

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
CONDENSED  STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS
FOR THE THREE MONTHS ENDED JUNE 30, 2012 AND 2011
AND FOR THE CUMULATIVE PERIOD MARCH 31, 2010 (INCEPTION) THROUGH JUNE 30, 2012
(UNAUDITED)
 
   
FOR THE THREE
   
FOR THE THREE
   
MARCH 31, 2009
 
   
MONTHS ENDED
   
MONTHS ENDED
   
(INCEPTION)
 
   
JUNE 30,
   
JUNE 30,
   
THROUGH
 
   
2012
   
2011
   
JUNE 30, 2012
 
                   
REVENUE
  $ -     $ -     $ -  
                         
COST OF REVENUES
    -       -       -  
                         
GROSS PROFIT
    -       -       -  
                         
OPERATING EXPENSES
                       
Professional fees
    13,605       13,635       160,174  
General and administrative
    9,627       7,263       69,142  
Advertising expense
    -       -       1,800  
Research and development
    -       -       157,300  
LOSS FROM OPERATIONS
    23,232       20,898       388,416  
                         
NET LOSS BEFORE OTHER EXPENSE
    (23,232 )     (20,898 )     (388,416 )
                         
OTHER INCOME (EXPENSE)
                       
Foreign currency exchange gain (loss)
    (502 )     51       (1,388 )
Total other expense
    (502 )     51       (1,388 )
                         
NET LOSS
  $ (23,734 )   $ (20,847 )   $ (389,804 )
                         
                         
WEIGHTED AVERAGE NUMBER OF SHARES OUTSTANDING
    114,150,000       114,150,000          
                         
BASIC AND DILUTED NET LOSS PER COMMON SHARE
  $ (0.00 )   $ (0.00 )        
                         
COMPREHENSIVE LOSS:
                       
Net loss
  $ (23,734 )   $ (20,847 )   $ (389,804 )
Currency translation adjustment
    312       -       313  
Total comprehensive loss
  $ (23,422 )   $ (20,847 )   $ (389,491 )
 
The accompanying notes are an integral part of these financial statements.
 
 
4

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
CONDENSED STATEMENTS OF CASH FLOW
FOR THREE MONTHS ENDED JUNE 30, 2012 AND 2011
AND FOR THE PERIOD MARCH 31, 2009 (INCEPTION) THROUGH JUNE 30, 2012
(UNAUDITED)
 
   
FOR THE THREE
   
FOR THE THREE
   
MARCH 31, 2009
 
   
MONTHS ENDED
   
MONTHS ENDED
   
(INCEPTION)
 
   
JUNE 30,
   
JUNE 30,
   
THROUGH
 
   
2012
   
2011
   
JUNE 30, 2012
 
CASH FLOWS FROM OPERATING ACTIVITIES:
                 
   Net (loss)
  $ (23,734 )   $ (20,847 )   $ (389,804.00 )
                         
Adjustments to reconcile net (loss) to net cash used in operating activities:
                       
    Common stock issued for services
    -       -       84,500  
                         
Change in assets and liabilities
                       
(Increase) in other current asset
    573       869       1,442  
    (Increase) Decrease in other receivables
    (662 )     512       (2,658 )
    Increase in accounts payable and accrued expenses
    1,019       19,214       61,948  
          Net cash (used in) operating activities
    (22,804 )     (252 )     (244,572 )
                         
CASH FLOWS FROM FINANCING ACTIVITIES:
                       
Proceeds from advances payable from shareholders
    22,652       (389 )     125,694  
Advances payable
    -       -       15,000  
    Proceeds from the issuance of common stock
    -       -       103,950  
          Net cash provided by financing activities
    22,652       (389 )     244,644  
                         
                         
EFFECT OF EXCHANGE RATES ON CASH AND CASH EQUIVALENTS
    312       -       313  
                         
NET INCREASE IN CASH AND CASH EQUIVALENTS
    160       (641 )     385  
 
                       
CASH AND CASH EQUIVALENTS - BEGINNING OF PERIOD
    225       1,064       -  
 
                       
CASH AND CASH EQUIVALENTS - END OF PERIOD
  $ 385     $ 423     $ 385  
                         
SUPPLEMENTAL CASH FLOW INFORMATION:
                       
  Cash paid during the period for:
                       
     Interest
  $ -     $ -     $ -  
     Income Taxes
  $ -     $ -     $ -  
 
The accompanying notes are an integral part of these financial statements.
 
 
5

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
CONDENSED  STATEMENT OF STOCKHOLDERS' EQUITY (DEFICIT)
FOR THE PERIOD MARCH 31, 2009 (INCEPTION) THROUGH JUNE 30, 2012
(UNAUDITED)
 
                     
Accumulated
             
               
Additional
   
Other
   
Accumulated
   
Total
 
   
Common Stock
   
Paid-In
   
Comprehensive
   
Deficit Since
   
Stockholders’
 
   
Shares
   
Par Value
   
Capital
   
Income
   
Inception
   
Deficit
 
                                     
Balance - March 31, 2009
    -     $ -     $ -     $ -       -     $ -  
                                                 
Net Loss for the Period
    -       -       -       -       -       -  
                                                 
Balance -  March 31, 2010
    -       -       -       -       -       -  
                                                 
Common Shares Issued for Services
    79,500,000       79,500       5,000       -       -       84,500  
                                                 
Common Shares Issued for Cash
    34,650,000       34,650       69,300       -       -       103,950  
                                                 
Net Loss for the Period
    -       -       -       -       (263,440 )     (263,440 )
                                                 
Balance -March 31, 2011
    114,150,000       114,150       74,300     $ -       (263,440 )     (74,990 )
                                                 
Foreign currency gain
    -       -       -       1       -       1  
                                                 
Net Loss for the Period
    -       -       -       -       (102,630 )     (102,630 )
                                                 
Balance - March 31, 2012
    114,150,000     $ 114,150     $ 74,300     $ 1     $ (366,070 )   $ (177,619 )
                                                 
Foreign currency gain
    -       -       -       312       -       312  
                                                 
Net Loss for the Period
    -       -       -       -       (23,734 )     (23,734 )
                                                 
Balance - June 30, 2012
    114,150,000       114,150       74,300       313       (389,804 )     (201,041 )

The accompanying notes are an integral part of these financial statements.
 
 
6

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)
 
NOTE 1 -  ORGANIZATION AND BASIS OF PRESENTATION
 
On March 31, 2009, Technologies Scan Corp (a corporation in the development stage) (the “Company”) was incorporated in the State of Nevada as “Pharmascan Corp.” On September 21, 2010, the Company filed a Certificate of Amendment to its Articles of Incorporation and changed its name to Technologies Scan Corp.
 
The Company was formed to sell their touch screen product called the Infoscan to pharmacies.  The Infoscan is a source of professional knowledge for natural products on a user friendly touch screen including a barcode reader tailored to products offered in a pharmacy.  The Infoscan guides customers in purchasing over the counter natural products and private label products.
 
Basis of Presentation

These condensed financial statements have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the instructions to Securities and Exchange Commission (“SEC”) Form 10-Q and Article 8 of SEC Regulation S-X. The principles for interim financial information do not require the inclusion of all the information and footnotes required by generally accepted accounting principles for complete financial statements. Therefore, these financial statements should be read in conjunction with the Company’s audited financial statements in Form 10-K filed with the SEC for the years ended March 31, 2012 and 2011 and the period from March 31, 2009 (inception) to March 31, 2012. The condensed financial statements included herein are unaudited; however, in the opinion of management, they contain all normal recurring adjustments necessary for a fair statement of the condensed results for the interim periods. Operating results for the three month periods ended June 30, 2012 and 2011 are not necessarily indicative of the results that may be expected for the year ending March 31, 2013.

Going Concern
 
The accompanying financial statements as of June 30, 2012 have been prepared assuming the Company will continue as a going concern. The Company has experienced recurring losses and negative cash flows from operations, has no revenue and has an accumulated deficit of $389,804 at June 30, 2012.  These factors raise substantial doubt about the Company's ability to continue as a going concern. Management intends to raise additional debt and/or equity financing to fund future operations.  There is no assurance that its plan can be implemented; or that the results will be of a sufficient level necessary to meet the Company’s ongoing cash needs.  No assurances can be given that the Company can obtain sufficient working capital through borrowings or that the continued implementation of its business plan will generate sufficient revenues in the future to sustain ongoing operations.
 
The accompanying financial statements do not include any adjustments to reflect the possible future effects on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the possible inability of the Company to continue as a going concern.

NOTE 2 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

 Development Stage Company
 
The Company is considered to be in the development stage as defined by ASC 915.  The Company has devoted substantially all of its efforts to the corporate formation, the raising of capital and attempting to generate customers for the sale of the Company’s products.
 
 
7

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)
 
NOTE 2 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
 
Use of Estimates
 
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosures of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ from those estimates.
 
Cash and Cash Equivalents
 
The Company considers all highly liquid debt instruments and other short-term investments with maturity of three months or less, when purchased, to be cash equivalents.

Research and Development
 
The Company accounts for research and development costs in accordance with Accounting Standards Codification subtopic 730-10, Research and Development (“ASC 730-10”). Under ASC 730-10, all research and development costs must be charged to expense as incurred. Accordingly, internal research and development costs are expensed as incurred.  Third-party research and development costs are expensed when the contracted work has been performed or as milestone results have been achieved. Company sponsored research and development costs related to both present and future products are expensed in the period incurred. The Company incurred $157,300 of research and development costs associated with its informatic concept and prototype for the year ended June 30, 2012 and for the cumulative period March 31, 2009 (Inception) through June 30, 2012.
 
Foreign Currency Translation and Transaction

The functional currency for Technologies Scan Corp. is the Canadian dollar.  The Company translates assets and liabilities to US dollars using period-end exchange ratesand translates revenues and expenses using average exchange rates during the period.  Exchange gains and losses arising from translation are included as a component of other comprehensive income.  

Transactions denominated in currencies other than the functional currency of the legal entity are re-measured to the functional currency of the legal entity at the period-end exchange rates.  Any associated transactional currency re-measurement gains and losses are recognized in current operations.
 
Comprehensive Income

Comprehensive loss reflects changes in equity that results from transactions and economic events from non-owner sources.  The Company had $312 and $1 in accumulated other comprehensive income for the periods ended June 30, 2012 and December 31, 2011, respectively, from its foreign currency translation.  As a result, total comprehensive losses for the periods ended June 30, 2012 and December 31, 2012 was $389,491and $366,069, respectively.
 
 
8

 

TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)
 
NOTE 2 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
 
Income Taxes
 
Deferred tax liabilities and assets are recognized for the expected future tax consequences of events that have been included in the financial statement or tax returns.  Deferred tax liabilities and assets are determined based on the difference between the financial statements and the tax basis of assets and liabilities using enacted tax rates in effect for the year in which the differences are expected to reverse.  Valuation allowances are established, when necessary, to reduce deferred tax assets to amounts that are expected to be realized.
 
Revenue Recognition
 
The criteria for revenue recognition are as follows:
 
1)  
Persuasive evidence of an arrangement exists;
2)  
Delivery has occurred or services have been rendered;
3)  
The seller’s price to the buyer is fixed or determinable, and
4)  
Collectability is reasonably assured.
 
Determination of criteria (3) and (4) will be based on management's judgments regarding the fixed nature of the selling prices of the products delivered and the collectability of those amounts. Provisions for discounts and rebates to customers, estimated returns and allowances, and other adjustments will be provided for in the same period the related sales are recorded.
 
Basic and Diluted Loss Per Common Share
 
Basic net loss per common share is computed using the weighted average number of common shares outstanding.  Diluted loss per share reflects the potential dilution from common stock equivalents, such as stock issuable pursuant to the exercise of stock options and warrants.  There were no dilutive potential common shares as of June 30, 2012 and 2011. Because the Company has incurred net losses and there are no potential dilutive shares, basic and diluted loss per common share are the same.
 
 
9

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)
 
NOTE 2 -  SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (CONTINUED)
 
Recently Issued Accounting Standards
 
There were various updates recently issued, and are not expected to a have a material impact on the Company's consolidated financial position, results of operations or cash flows.
 
NOTE 3 -  STOCKHOLDERS' EQUITY (DEFICIT)
 
The Company was established with one class of stock, common stock – 200,000,000 shares authorized at a par value of $0.001.
 
On April 1, 2010 the Company issued 77,000,000 shares of common stock to the Company’s founders at a value of $77,000 ($0.001 per share) for services rendered by the Company’s two founders and a consultant, which included the following:  preparing the articles of incorporation, database and software development, and identifying strategic business partners.
 
In December 2010, the Company issued 2,500,000 shares of the Company's common stock for services rendered in connection with the preparation of this registration statement during 2011.  Those 2,500,000 shares were valued at $7,500 ($0.003) per share based on the latest sale of shares to unrelated third parties.  No quoted market price was available to value the shares on the date they were granted. 

During the period ended December 31, 2010 the Company raised $103,950 through the sale of 34,650,000 shares of common stock ($0.003 per share).
 
The Company has not issued any options or warrants to date.
 
 
10

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)
 
NOTE 4 - ADVANCES PAYABLE

As of June 30, 2012 and December 31, 2011, the Company had advances payable outstanding to a third party of $15,000, respectively.  These advances are non-interest bearing, unsecured and are payable on demand.

NOTE 5 - ADVANCES PAYABLE - SHAREHOLDERS
 
As of June 30, 2012 and March 31, 2012, the Company had advances payable of $78,000, respectively due to two shareholders of the Company.  These advances are non-interest bearing, unsecured and are payable on demand.

As of June 30, 2012 and March 31, 2012, the Company also had related party advances payable of $47,694 and $25,042, respectively, due to a director who is also a related party shareholder of the Company.   These related party advances are non-interest bearing, unsecured and are payable on demand.

NOTE 6 - INCOME TAXES
 
As of June 30, 2012 and March 31, 2012, the Company had no significant current or deferred taxes.
 
The net deferred tax asset consists of the following at June 30, 2012 and March 31, 2012:
 
   
JUNE 30,
2012
   
MARCH 31,
2012
 
Net taxable losses
  $ 103,565     $ 95,496  
Deferred income tax liabilities
    -       -  
Subtotal
    103,565       95,496  
Valuation allowance
    (103,565 )     (95,496  
Net
  $ -     $ -  
 
Based upon the net operating losses incurred since inception, management has determined that the deferred tax asset as of June 30, 2012, will likely not be recognized.  Consequently, the Company has established a valuation allowance against the entire deferred tax asset.
 
 
11

 
 
TECHNOLOGIES SCAN CORP.
(A DEVELOPMENT STAGE COMPANY)
NOTES TO CONDENSED FINANCIAL STATEMENTS
JUNE 30, 2012
(UNAUDITED)

NOTE 6 - INCOME TAXES (CONTINUED)
 
As of June 30, 2012, the Company had a net operating loss carry forward of approximately $389,804 with an initial carry forward period of 20 years.A reconciliation of income taxes computed at the statutory income tax rate to the provision (benefit) for income taxes for the periods ended June 30, 2012 and March 31, 2012, is as follows:
 
   
JUNE 30,
2012
   
MARCH 31,
2012
 
Statutory tax at 34%
 
$
(132,533)
)
 
$
(124,464)
 
Permanent differences – primarily stock-based compensation
   
28,968
     
28,968
 
Valuation allowance
   
103,565
     
95,496
 
Provision (benefit) for income taxes
 
$
-
   
$
-
 

NOTE 7 - COMMITMENTS AND CONTINGENCIES
 
On July 5, 2010, the Company entered into a lease agreement that expires on October 31, 2013 for office space in Mirabel, Quebec.  The lease calls for monthly payments of approximately $1,887 (CDN$). Rent expense for the period ended June 30, 2012 and 2011 was approximately$5,591 and $5,127 (USD$).
 
The scheduled lease payments for the office space are as follows:
 
June 30, 2013
 
$
22,644
 
June 30, 2014
   
7,548
 
Total
 
$
30,192
 
 
 
12

 
 
Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

Forward-looking Statements.

This Quarterly Report of Technologies Scan Corp. on Form 10-Q contains forward-looking statements, particularly those identified with the words, “anticipates,” “believes,” “expects,” “plans,” “intends,” “objectives,” and similar expressions. These statements reflect management’s best judgment based on factors known at the time of such statements. The reader may find discussions containing such forward-looking statements in the material set forth under “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” generally, and specifically therein under the captions “Liquidity and Capital Resources” as well as elsewhere in this Quarterly Report on Form 10-Q. Actual events or results may differ materially from those discussed herein. The forward-looking statements specified in the following information have been compiled by our management on the basis of assumptions made by management and considered by management to be reasonable. Our future operating results, however, are impossible to predict and no representation, guaranty, or warranty is to be inferred from those forward-looking statements. The assumptions used for purposes of the forward-looking statements specified in the following information represent estimates of future events and are subject to uncertainty as to possible changes in economic, legislative, industry, and other circumstances. As a result, the identification and interpretation of data and other information and their use in developing and selecting assumptions from and among reasonable alternatives require the exercise of judgment. To the extent that the assumed events do not occur, the outcome may vary substantially from anticipated or projected results, and, accordingly, no opinion is expressed on the achievability of those forward-looking statements. No assurance can be given that any of the assumptions relating to the forward-looking statements specified in the following information are accurate, and we assume no obligation to update any such forward-looking statements.
 
Critical Accounting Policies and Estimates.  Our Management’s Discussion and Analysis of Financial Condition and Results of Operations section discusses our financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States of America.  The preparation of these financial statements requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period.  On an on-going basis, management evaluates its estimates and judgments, including those related to revenue recognition, accrued expenses, financing operations, and contingencies and litigation.  Management bases its estimates and judgments on historical experience and on various other factors that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying value of assets and liabilities that are not readily apparent from other sources.  Actual results may differ from these estimates under different assumptions or conditions.  The most significant accounting estimates inherent in the preparation of our financial statements include estimates as to the appropriate carrying value of certain assets and liabilities which are not readily apparent from other sources.  In addition, these accounting policies are described at relevant sections in this discussion and analysis and in the notes to the financial statements included in this Quarterly Report on Form 10-Q for the three months ended June 30, 2012.

The following discussion of our financial condition and results of operations should be read in conjunction with our condensed unaudited interim financial statements for the three months ended June 30, 2012 and 2011, together with notes thereto, as included in this Quarterly Report on Form 10-Q, and our audited financial statements for the years ended March 31, 2012 and 2011, together with notes thereto, as included in our Annual Report on Form 10-K filed on July 16, 2012.
 
Our Background. We were incorporated as Pharmascan Corp. in the State of Nevada on March 31, 2009. On September 21, 2010, we filed a Certificate of Amendment to our Articles of Incorporation and changed our name to Technologies Scan Corp. 

Our Business.  We are a development stage company whose plan of operation is selling touch screen computer products to pharmacies.  We have developed full software and databases for pharmacy products by gathering relevant information from the pharmacy industry and preparing the information for programming by our software consultants.  We intend to use this expertise to develop customized software and database programs for specific retail pharmacies.  We believe the Infoscan, one of our programs, provides pharmacy product information in a unique and innovative way, through a touch screen and barcode reader.  The Infoscan can be tailored to any pharmacy’s product offerings.  The Infoscan guides customers in purchasing over the counter natural products and private label products in what we believe is an efficient manner that would allow pharmacy employees to perform other tasks.
 
 
13

 
 
Our Infoscan products will be used at pharmacies to assist customers with their purchases.  In addition to selling Infoscan products, we intend to provide services such as location and installation advice, personalized programming onto the Infoscan, and employee training to use the product.  Our Infoscan products include a database for products, barcodes reader and equipment including computer screens, optic readers, master cards, hard discs and adapted support.

We hope to generate product revenues predominantly from sales of our Infoscan programs to potential clients in the retail pharmacy industry.
 
For the three months ended June 30, 2012, as compared to the three months ended June 30, 2011.

Results of Operations.

Revenues. We had no revenues for the three months ended June 30, 2012 and 2011.
 
Operating Expenses.  Our operating expenses increased by $2,334 from $20,898 for the three months ended June 30, 2011 to $23,232 for the three months ended June 30, 2012.  The overall increase between the comparable periods is primarily due to an increase in general and administrative fees, which increased from $7,263 for the three months ended June 30, 2011 to $9,627 for the three months ended June 30, 2012.

Other Income (Expense).  We had a foreign exchange gain of $51 for the three months ended June 30, 2011 compared to a loss of $502 for the three months ended June 30, 2012.  This decrease is a result of paying vendors in Canadian dollars.
 
Net Loss.  Our net loss increased $2,887 from a net loss of $20,847 for the three months ended June 30, 2011 to a net loss of $23,734 for the three months ended June 30, 2012.  Our net loss increased primarily due to an increase in our general and administrative expenses for the three months ended June 30, 2012.

Liquidity and Capital Resources.  On April 1, 2010, we issued 77,000,000 shares of common stock to our two founders and a consultant in exchange for services valued at $77,000, or $0.001 per share.  During the period from April 1, 2010 through March 31, 2012, we sold 34,650,000 shares of common stock in exchange for $103,950, or $0.003 per share.  These proceeds are being used to pay for the development of our products, overhead expenses and working capital.  In addition, we were advanced $103,042 from our director and shareholders since inception.  The advances are non-interest bearing and payable on demand.  We also received an advance of $15,000 from a third party during our fiscal year ended March 31, 2012.  The advance is non-interest bearing and payable on demand.

As of June 30, 2012, we had liabilities of $202,642, of which $61,948 were represented by accounts payable and accrued expenses, $125,694 of advances payable to our shareholders, and $15,000 due to an unrelated third party.
 
During 2012, we expect to incur significant costs associated with updating and maintaining our database and website.  We expect that the costs of updating and maintaining our database and website will be approximately $80,000 and will continue to impact our liquidity.  We will need to obtain funds to pay those expenses.

During 2012, we expect to incur significant accounting costs associated with the audit and review of our financial statements.  We expect that the legal and accounting costs of being a public company will be approximately $50,000 per year and will continue to impact our liquidity.  We will need to obtain funds to pay those expenses.

Other than expenses for updating and maintaining our database and website and the anticipated increases in legal and accounting costs due to the reporting requirements of being a reporting company, we are not aware of any other known trends, events or uncertainties, which may affect our future liquidity.
 
 
14

 

As of June 30, 2012, we had a cash balance of $385.  We have no currently planned material commitments for capital expenditures; however, we will need operating capital to continue our current business plans and we presently have no source of capital.  Although we are considering various debt or equity financings, there can be no assurance that any financing will be available to us on terms acceptable to us or at the time that we would require such financing, or at all.  Failure to obtain any such financing will result in our inability to effectuate our business plan.  The notes to our financial statements at June 30, 2012 disclose uncertainty as to our ability to continue as a going concern.
 
In the opinion of management, available funds will not satisfy our working capital requirements for the next twelve months.  Our forecast for the period for which our financial resources will be adequate to support our operations involves risks and uncertainties and actual results could fail as a result of a number of factors.  We intend to pursue capital through public or private financing as well as borrowings and other sources, such as our officers and directors.  We cannot guarantee that additional funding will be available on favorable terms, if at all.

We are not currently conducting any research and development activities.  We do not anticipate conducting such activities in the near future. We do not anticipate that we will purchase or sell any significant equipment.  In the event that we generate significant revenues and expand our operations, then we may need to hire additional employees or independent contractors as well as purchase or lease additional equipment.

Off-Balance Sheet Arrangements. We have no off-balance sheet arrangements.
 
Item 3.  Quantitative and Qualitative Disclosures about Market Risk.
 
Not Applicable.
 
Item 4.  Controls and Procedures.
 
Evaluation of disclosure controls and procedures. We maintain controls and procedures that are designed to ensure that information required to be disclosed in the reports that we file or submit under the Securities Exchange Act of 1934 is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management including our principal executive and principal financial officers, as appropriate, to allow timely decisions regarding required disclosures. Based upon their evaluation of those controls and procedures performed as of the end of the period covered by this report, our principal executive officer and our principal financial officer concluded that our disclosure controls and procedures were effective.
 
Changes in internal controls over financial reporting.   There was no change during our most recently completed fiscal quarter that has materially affected or is reasonably likely to materially affect, our internal control over financial reporting, as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act. 
 
 
15

 
  
PART II - OTHER INFORMATION

Item 1. Legal Proceedings.
 
None.
 
Item 1A. Risk Factors.
 
Not applicable.
 
Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.
 
None.
 
Item 3.  Defaults Upon Senior Securities.
 
None.
 
Item 4.   Mine Safety Disclosures.
 
Not applicable.
 
Item 5.  Other Information.
 
None.
 
16

 

Item 6.  Exhibits.

31.1
 
Certification of Principal Executive Officer, Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002
     
31.2
 
Certification of Principal Financial Officer, Required By Rule 13a-14(A) of the Securities Exchange Act of 1934, As Amended, As Adopted Pursuant To Section 302 of the Sarbanes-Oxley Act of 2002
     
32.1
 
Certification of Principal Executive Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
     
32.2
 
Certification of Principal Financial Officer, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
 
101.INS **
 
XBRL Instance Document
     
101.SCH **
 
XBRL Taxonomy Extension Schema Document
     
101.CAL **
 
XBRL Taxonomy Extension Calculation Linkbase Document
     
101.DEF **
 
XBRL Taxonomy Extension Definition Linkbase Document
     
101.LAB **
 
XBRL Taxonomy Extension Label Linkbase Document
     
101.PRE **
 
XBRL Taxonomy Extension Presentation Linkbase Document
_____________
** XBRL (Extensible Business Reporting Language) information is furnished and not filed or a part of a registration statement or prospectus for purposes of Sections 11 or 12 of the Securities Act of 1933, as amended, is deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, and otherwise is not subject to liability under these sections.

 
17

 
 
 
SIGNATURES
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
  Technologies Scan Corp.,
a Nevada corporation
 
       
August 14, 2012
By:
/s/ Ghislaine St-Hilaire  
    Ghislaine St-Hilaire  
    President, Director  
    (Principal Executive Offic  
 
 
August 14, 2012
By:
/s/ Gilbert Pomerleau
 
 
Its:
Gilbert Pomerleau
Chief Financial Officer, Secretary, Treasurer, Director
(Principal Financial and Accounting Officer)